LIM NEW

Kisspeptin: Revolutionizing Hormone Therapy for Reproductive Health Kisspeptin hormone therapy offers promising advancements in managing reproductive disorders. It regulates gonadotropin release, improves luteinizing hormone (LH) pulsatility, and aids fertility treatments such as in vitro fertilization (IVF). This innovative therapy shows potential in addressing conditions like hypothalamic amenorrhea and hypogonadotropic hypogonadism, marking a significant step in reproductive healthcare. #Horm

✨ For years, women were told hormone therapy had an expiration date — “Start before 60 or don’t start at all.” But new research says that’s not the whole story. A 2024 study of over 10 million women found that hormone therapy can still be safe and effective after 65 when the type, dose, and route are chosen carefully. 💡 Key findings: • Transdermal estradiol and low-dose estrogen-only options showed lower risks of blood clots, stroke, and dementia. • Oral combined therapy (like Prempro) carried